Primary contact

Limbix is developing VR-based Prescription Digital Therapeutics (PDTs) for mental health. Specifically, the company is building PDTs for treatments of conditions including Adolescent Depression, Major Depressive Disorder, Social Anxiety, Panic Disorder, Chronic Pain, Adolescent Social Anxiety, and Alcohol Use Disorder. To make that happen, Limbix is collaborating with top university and hospital partners to build content for the Limbix VR platform. Among its partners are institutions such as UCLA, Stanford, USC, Mayo Clinic, John Volken Academy and Tulane University. The company is also selling the medical-grade Limbix VR Kit to 10,000+ mental health clinics to enhance therapy, make it more efficient, and help clinicians.
Primary contact

Funding 💰

Total $7M
Select investors Sequoia Capital, Storm Ventures, Maverick Ventures, NextGen Venture Partners, JAZZ Venture Partners
Last update: October 5, 2020